Harnessing Pluripotency from Differentiated Cells: A Regenerative Source for Tissue-Specific Stem Cell Therapies

2006 ◽  
Vol 1 (3) ◽  
pp. 325-331 ◽  
Author(s):  
Ilham Saleh Abuljadayel
Keyword(s):  
Stem Cell ◽  
Stem Cell Therapies ◽  
Tissue Specific ◽  
Cell Therapies ◽  
Differentiated Cells

scholarly journals Disease-Modifying Drugs and Stem Cell Therapies for the Treatment of Myelin Degeneration due to Multiple Sclerosis

2020 ◽  
pp. 1-5
Author(s):  
Darren Ioos ◽  
◽  
Vincent Gallicchio ◽  
Keyword(s):  
Multiple Sclerosis ◽  
Nervous System ◽  
Stem Cell ◽  
Signal Propagation ◽  
Stem Cell Therapies ◽  
Disease Modifying Drugs ◽  
Cell Therapies ◽  
Differentiated Cells ◽  
Pns Myelin ◽  
Magnetic Resonance Imaging Mri

Myelin, a modified plasma membrane wrapped around axons, is an essential part of signal propagation in the nervous system. Formed by oligodendrocytes in the central nervous system (CNS) and Schwann cells in the peripheral nervous system (PNS), myelin lowers the amount of energy needed to send or receive signals. Multiple Sclerosis (MS) is an autoimmune, hyperinflammatory disease that attacks the nervous system, specifically myelin. MS is characterized by three types of lesions in the brain and along the blood brain barrier, making it very difficult to diagnose through conventional magnetic resonance imaging (MRI) and even more difficult to treat. It has an unpredictable pathophysiology that cannot be cured by current drug therapies. Stem cell therapies have been heavily researched in recent years to try to combat the autoimmune disease by stopping demyelination and recovering lost function through the regeneration of differentiated cells

Sternal bone marrow is a suitable autologous cell source for cardiac stem cell therapies

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
M. Arar ◽  
A. Rotärmel ◽  
A.-K. Knoefel ◽  
H. Baraki ◽  
I. Kutschka ◽  
...  
Keyword(s):  
Bone Marrow ◽  
Stem Cell ◽  
Cardiac Stem Cell ◽  
Stem Cell Therapies ◽  
Cell Therapies ◽  
Autologous Cell ◽  
Cell Source

Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies

2019 ◽  
Vol 14 (6) ◽  
pp. 454-459
Author(s):  
Xuejing Hou ◽  
Ying Liu ◽  
Isabelle Streuli ◽  
Patrick Dällenbach ◽  
Jean Dubuisson ◽  
...  
Keyword(s):  
Stem Cell ◽  
Molecular Mechanisms ◽  
Uterine Cavity ◽  
Stem Cell Therapies ◽  
Intrauterine Adhesions ◽  
Asherman’S Syndrome ◽  
Cell Therapies ◽  
Fibrotic Process ◽  
Physical Barriers

Asherman’s Syndrome or Intrauterine adhesions is an acquired uterine condition where fibrous scarring forms within the uterine cavity, resulting in reduced menstrual flow, pelvic pain and infertility. Until recently, the molecular mechanisms leading to the formation of fibrosis were poorly understood, and the treatment of Asherman’s syndrome has largely focused on hysteroscopic resection of adhesions, hormonal therapy, and physical barriers. Numerous studies have begun exploring the molecular mechanisms behind the fibrotic process underlying Asherman’s Syndrome as well as the role of stem cells in the regeneration of the endometrium as a treatment modality. The present review offers a summary of available stem cell-based regeneration studies, as well as highlighting current gaps in research.

Stem Cell Therapies

2016 ◽  
Vol 5 (2) ◽  
pp. 145-151
Author(s):  
Ana Muñoz ◽  
Víctor Galvez ◽  
María Camarasa
Keyword(s):  
Stem Cell ◽  
Stem Cell Therapies ◽  
Cell Therapies

Public Opinion and Expectations of Stem Cell Therapies in Orthopaedics*

2021 ◽  
Author(s):  
Richard N. Puzzitiello ◽  
Jeremy Dubin ◽  
Mariano E. Menendez ◽  
Michael A. Moverman ◽  
Nicholas R. Pagani ◽  
...  
Keyword(s):  
Stem Cell ◽  
Public Opinion ◽  
Stem Cell Therapies ◽  
Cell Therapies

Equine Models for the Investigation of Mesenchymal Stem Cell Therapies in Orthopaedic Disease

2017 ◽  
Vol 25 (1) ◽  
pp. 41-49 ◽  
Author(s):  
Aimée C. Colbath ◽  
David D. Frisbie ◽  
Steven W. Dow ◽  
John D. Kisiday ◽  
C. Wayne McIlwraith ◽  
...  
Keyword(s):  
Stem Cell ◽  
Mesenchymal Stem Cell ◽  
Stem Cell Therapies ◽  
Cell Therapies

scholarly journals Stem cell therapies for systemic sclerosis

2014 ◽  
Vol 168 (3) ◽  
pp. 328-337 ◽  
Author(s):  
Paola Cipriani ◽  
Piero Ruscitti ◽  
Roberto Giacomelli
Keyword(s):  
Stem Cell ◽  
Systemic Sclerosis ◽  
Stem Cell Therapies ◽  
Cell Therapies

Urine Is a Highly Cytotoxic Agent: Does It Influence Stem Cell Therapies in Urology?

2012 ◽  
Vol 44 (5) ◽  
pp. 1439-1441 ◽  
Author(s):  
J. Adamowicz ◽  
T. Kloskowski ◽  
J. Tworkiewicz ◽  
M. Pokrywczyńska ◽  
T. Drewa
Keyword(s):  
Stem Cell ◽  
Cytotoxic Agent ◽  
Stem Cell Therapies ◽  
Cell Therapies
Sign in / Sign up

Export Citation Format

Share Document